Serotonergic antagonist effects on trafficking of serotonin 5-HT(2A) receptors in vitro and in vivo

Annals of the New York Academy of Sciences

Volumn 861, Issue , 1998, Pages 121-127

  Willins, D L ^a   Alsayegh, L ^a   Berry, S A ^a   Backstrom, J R ^a   Sanders Bush, E ^b   Friedman, L ^a   Khan, N ^a   Roth, B L ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CLOZAPINE; OLANZAPINE; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL STRAIN 3T3; CELL SURFACE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITE; GENETIC TRANSFECTION; IMMUNOREACTIVITY; INTERNALIZATION; MALE; MOUSE; NONHUMAN; PERIKARYON; PYRAMIDAL NERVE CELL; RAT; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0032433447     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10182.x     Document Type: Conference Paper

References (19)

1. 1. FREEDMAN, N. J. & R. J. LEFKOWITZ. 1996. Desensitization of G protein-coupled receptors. Recent Prog. Horm. Res. 51: 319-351; discussion 352-353.
2. 2. CHUANG, T. T., L. IACOVELLI, M. SALLESE & A. DE BIASI. 1996. G protein-coupled receptors: Heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17: 416-442.
3. 3. PEROUTKA, S. J. & S. H. SNYDER. 1980. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210 (4465): 88-90.
4. 2 binding site after chronic administration of agonists and antagonists. Neuropharmacology 25: 1267-1271.
5. 2 receptor mRNA levels. Eur. J. Pharmacol. 207: 169-172.
6. 2C): Where structure meets function. Pharmacol. Therap. 79: 231-244.
7. 2A) receptor desensitization can occur without down-regulation. J. Pharmacol. Exp. Ther. 275: 1638-1646.
8. 2A receptor occurs via the endosome pathway in vitro. Mol. Pharmacol. 50(2):306-313.
9. 2A receptors are located on pyramidal and intrinsic neurons in the medial prefrontal cortex. Synapse 27: 79-82.
10. 2C receptors. J. Neurosci. Methods 77: 109-117.
11. 11. WILLINS D. L., L. ALSAYEGH, S. A. BERRY, J. R. BACKSTROM, E. SANDERS-BUSH, L. FRIEDMAN, N. KAHN & B. L. ROTH. 1997. The atypical antipsychotic drug, clozapine, alters the subcellular distribution of serotonin 2A receptors in vitro and in vivo. Soc. Neurosci. Abst. 23:385.22.
12. 12. ROTH, B. L. & H. Y. MELTZER. 1995. The role of serotonin in schizophrenia. In Psychopharmacology: The Fourth Generation of Progress. F. E. Bloom & D. J. Kupfer, Eds. :1215-1227. Raven Press. New York.
13. 13. ROTH, B. L., H. Y. MELTZER, & N. KAHN. 1998. Binding of typical and atypical antipsychotic drugs to multiple neurotransmitter receptors. Adv. Pharmacol. 42: 482-485.
14. 14. PUCAK, M. L., J. B. LEVITT, J. S. LUND & D. A. LEWIS. 1996. Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J. Comp. Neurol. 376 (4): 614-630.
15. 15. SHEPHERD, G. M., R. K. BRAYTON, J. P. MILLER, I. SEGEV, J. RINZEL & W. RALL. 1985. Signal enhancement in distal cortical dendrites by means of interactions between active dendritic spines. Proc. Natl. Acad. Sci. USA 82: 2192-2195.
16. 16. BENES, F. M. 1995. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch. Gen. Psychiatry 52 (12): 1015-1018.
17. 17. SELEMON, L. D., G. RAJKOWSKA, & P. S. GOLDMAN RAKIC 1995. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 52: 805-818.
18. 18. ARANEDA, R. & R. ANDRADE. 1991. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40: 399-412.
19. 19. AGHAJANIAN, G. K. & G. J. MAREK. 1997. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36: 589-599.